Cargando…
COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
BACKGROUND AND OBJECTIVE: The Covid-19 pandemic especially affects cancer patients with higher incidence and mortality according to published series of original pandemic foci. The study aims to determine the mortality in our center due to covid-19 in cancer patients during the first 3 weeks of the e...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396880/ https://www.ncbi.nlm.nih.gov/pubmed/32838040 http://dx.doi.org/10.1016/j.medcle.2020.05.012 |
_version_ | 1783565659921186816 |
---|---|
author | Lara Álvarez, Miguel Ángel Rogado Revuelta, Jacobo Obispo Portero, Berta Pangua Méndez, Cristina Serrano Montero, Gloria López Alfonso, Ana |
author_facet | Lara Álvarez, Miguel Ángel Rogado Revuelta, Jacobo Obispo Portero, Berta Pangua Méndez, Cristina Serrano Montero, Gloria López Alfonso, Ana |
author_sort | Lara Álvarez, Miguel Ángel |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: The Covid-19 pandemic especially affects cancer patients with higher incidence and mortality according to published series of original pandemic foci. The study aims to determine the mortality in our center due to covid-19 in cancer patients during the first 3 weeks of the epidemic. MATERIAL AND METHODS: The cancer patients who died of covid-19 during the analysis period have been reviewed describing the oncological and the covid-19 infection characteristics and the treatments established. RESULTS: Confirmed cases covid-19: 1069 with 132 deaths (12.3%). With cancer 36 patients (3.4%), 15 deceased (41.6%). Of the deceased, only 6 patients (40%) were in active treatment. The most frequent associated tumor was lung (8/15 patients, 53.3%), 11 with metastatic disease (11/15, 73.3%). No specific treatment was established in 40 % (6/15) of the patients. The rest of them received treatments with the active protocols. CONCLUSION: Covid-19 mortality in cancer patients is almost four times higher than that of the general population. Until we have effective treatments or an effective vaccine, the only possibility to protect our patients is to prevent the infection with the appropriate measures. |
format | Online Article Text |
id | pubmed-7396880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73968802020-08-03 COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() Lara Álvarez, Miguel Ángel Rogado Revuelta, Jacobo Obispo Portero, Berta Pangua Méndez, Cristina Serrano Montero, Gloria López Alfonso, Ana Med Clin (Engl Ed) Brief Report BACKGROUND AND OBJECTIVE: The Covid-19 pandemic especially affects cancer patients with higher incidence and mortality according to published series of original pandemic foci. The study aims to determine the mortality in our center due to covid-19 in cancer patients during the first 3 weeks of the epidemic. MATERIAL AND METHODS: The cancer patients who died of covid-19 during the analysis period have been reviewed describing the oncological and the covid-19 infection characteristics and the treatments established. RESULTS: Confirmed cases covid-19: 1069 with 132 deaths (12.3%). With cancer 36 patients (3.4%), 15 deceased (41.6%). Of the deceased, only 6 patients (40%) were in active treatment. The most frequent associated tumor was lung (8/15 patients, 53.3%), 11 with metastatic disease (11/15, 73.3%). No specific treatment was established in 40 % (6/15) of the patients. The rest of them received treatments with the active protocols. CONCLUSION: Covid-19 mortality in cancer patients is almost four times higher than that of the general population. Until we have effective treatments or an effective vaccine, the only possibility to protect our patients is to prevent the infection with the appropriate measures. Elsevier España, S.L.U. 2020-09-11 2020-08-03 /pmc/articles/PMC7396880/ /pubmed/32838040 http://dx.doi.org/10.1016/j.medcle.2020.05.012 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Report Lara Álvarez, Miguel Ángel Rogado Revuelta, Jacobo Obispo Portero, Berta Pangua Méndez, Cristina Serrano Montero, Gloria López Alfonso, Ana COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title | COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title_full | COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title_fullStr | COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title_full_unstemmed | COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title_short | COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic() |
title_sort | covid-19 mortality in cancer patients in a madrid hospital during the first 3 weeks of the epidemic() |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396880/ https://www.ncbi.nlm.nih.gov/pubmed/32838040 http://dx.doi.org/10.1016/j.medcle.2020.05.012 |
work_keys_str_mv | AT laraalvarezmiguelangel covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic AT rogadorevueltajacobo covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic AT obispoporteroberta covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic AT panguamendezcristina covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic AT serranomonterogloria covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic AT lopezalfonsoana covid19mortalityincancerpatientsinamadridhospitalduringthefirst3weeksoftheepidemic |